Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-03 FOEHR MATTHEW W President and COO Grant or award +6,595 167,198
2021-02-03 FOEHR MATTHEW W President and COO Grant or award · Employee Stock Option (right to buy) +13,136 13,136
2021-02-03 HIGGINS JOHN L Chief Executive Officer Grant or award +12,608 286,030
2021-02-03 HIGGINS JOHN L Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +25,113 25,113
2021-02-03 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +10,819 41,752
2021-02-03 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award · Employee Stock Option (right to buy) +11,591 11,591
2021-01-27 HIGGINS JOHN L Chief Executive Officer Option exercise +40,000 $14.47 $579K 283,422
2021-01-27 HIGGINS JOHN L Chief Executive Officer Sale −40,000 $182.00 $7.3M 243,422
2021-01-27 HIGGINS JOHN L Chief Executive Officer Option exercise +30,000 $21.92 $658K 273,422
2021-01-27 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −40,000 69,000
2021-01-27 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −30,000 65,616
2021-01-27 Davis Todd C Director Option exercise +2,456 $113.50 $279K 52,761
2021-01-27 Davis Todd C Director Option exercise · Non-Qualified Stock Option (right to buy) −2,456 0
2021-01-25 HIGGINS JOHN L Chief Executive Officer Option exercise +50,000 $14.47 $724K 285,310
2021-01-25 HIGGINS JOHN L Chief Executive Officer Sale −50,000 $159.00 $8.0M 235,310
2021-01-25 HIGGINS JOHN L Chief Executive Officer Grant or award +5,946 241,256
2021-01-25 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −2,845 $156.01 $444K 238,411
2021-01-25 HIGGINS JOHN L Chief Executive Officer Grant or award +9,607 248,018
2021-01-25 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −4,596 $156.01 $717K 243,422
2021-01-25 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −50,000 109,000

Page 36 of 43 · 858 trades